US Stock MarketDetailed Quotes
ICUI ICU Medical
- 171.960
- -2.850-1.63%
Close Nov 14 16:00 ET
- 171.960
- 0.0000.00%
Post 17:41 ET
4.21BMarket Cap-37710P/E (TTM)
175.090High162.145Low433.97KVolume174.280Open174.810Pre Close73.62MTurnover1.92%Turnover RatioLossP/E (Static)24.48MShares196.26152wk High2.06P/B3.88BFloat Cap82.82052wk Low--Dividend TTM22.55MShs Float321.700Historical High--Div YieldTTM7.41%Amplitude4.833Historical Low169.638Avg Price1Lot Size
ICU Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.32%36.02M | 5,665.47%82.04M | 11.08%45.77M | 367.51%166.2M | 5,434.25%91.27M | 1,424.69%35.21M | 97.60%-1.47M | 3,170.12%41.2M | -123.22%-62.13M | -102.07%-1.71M |
| Net income from continuing operations | -555.69%-32.98M | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M | -172.03%-74.29M | -177.97%-15.54M |
| Operating gains losses | -64.50%262K | -101.99%-13K | -117.71%-65K | 4.93%2.11M | 192.39%352K | -65.25%738K | 298.18%652K | -38.42%367K | 21.67%2.01M | -166.96%-381K |
| Depreciation and amortization | -4.82%55.6M | -3.65%55.4M | -0.36%55.5M | -2.71%228.77M | 0.61%57.16M | -0.39%58.42M | -13.61%57.5M | 4.82%55.7M | 162.16%235.15M | 145.58%56.81M |
| Other non cash items | 408.39%10.66M | -31.78%13.51M | 28.49%14.2M | 2.26%37.59M | -41.32%10.2M | -150.30%-3.46M | 308.28%19.8M | -49.78%11.05M | 24.63%36.76M | 217.14%17.39M |
| Change In working capital | 64.24%-13.49M | 129.82%24.49M | 113.74%4.1M | 55.35%-135.6M | 120.17%14.06M | 40.27%-37.71M | 31.35%-82.11M | 41.82%-29.84M | -2,119.61%-303.73M | -375.28%-69.71M |
| -Change in receivables | -391.43%-18.23M | 79.42%-7.25M | -82.97%13.97M | 353.96%48.64M | 154.43%5.55M | 52.83%-3.71M | -49.42%-35.23M | 264.75%82.03M | -239.23%-19.15M | -202.48%-10.2M |
| -Change in inventory | -224.54%-11.68M | 125.99%6.93M | 128.69%14.16M | 96.98%-6.08M | 223.00%60.58M | 118.10%9.38M | 58.23%-26.67M | -36.49%-49.37M | -1,066.11%-201.1M | -1,244.13%-49.26M |
| -Change in prepaid assets | -82.56%1.45M | -741.54%-6.9M | -400.73%-5.74M | -49.04%11.67M | -86.67%377K | -45.90%8.31M | -48.83%1.08M | -26.85%1.91M | 387.26%22.9M | 124.54%2.83M |
| -Change in payables and accrued expense | 141.57%11.89M | 2,367.81%40.87M | 76.99%-11.19M | -350.82%-82.78M | 32.75%-7.2M | -872.70%-28.61M | 114.24%1.66M | -18,379.70%-48.62M | -313.36%-18.36M | -139.22%-10.71M |
| -Change in other current assets | -4.12%-6.42M | 4.58%-5.96M | 19.98%-5.16M | -15.99%-24.7M | -547.47%-5.84M | -16.90%-6.16M | -111.72%-6.25M | 55.13%-6.45M | -1.20%-21.29M | 117.52%1.3M |
| -Change in other working capital | 156.14%9.5M | 80.88%-3.19M | 79.14%-1.95M | -23.41%-82.36M | -969.08%-39.42M | 1.92%-16.92M | 15.24%-16.69M | 64.26%-9.33M | -7,735.47%-66.73M | -234.17%-3.69M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.66%36.1M | 5,659.91%81.95M | 11.02%45.79M | 367.51%166.2M | 5,434.25%91.27M | 1,422.78%35.16M | 97.60%-1.47M | 3,173.40%41.25M | -123.22%-62.13M | -102.07%-1.71M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 6.72%-22.86M | -23.21%-21.69M | -17.64%-17.86M | 95.39%-87.95M | -27.72%-30.65M | -95.63%-24.51M | -239.10%-17.61M | 99.19%-15.18M | -2,005.56%-1.91B | 27.15%-24M |
| Net PPE purchase and sale | 7.25%-19.91M | -6.47%-19.47M | -12.04%-15.92M | 7.11%-83.89M | -38.62%-29.94M | -3.83%-21.47M | 25.17%-18.28M | 39.82%-14.21M | -31.76%-90.31M | 2.18%-21.6M |
| Net intangibles purchase and sale | 4.46%-2.95M | -13.73%-2.41M | -16.67%-2.95M | -8.42%-9.78M | 17.21%-2.04M | -45.80%-3.09M | -3.21%-2.12M | -6.07%-2.53M | 28.58%-9.02M | -1.95%-2.46M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -12,660.61%-1.84B | --0 |
| Net investment purchase and sale | --0 | --0 | -66.67%500K | -87.22%4.22M | --1.3M | --0 | -93.33%1.42M | -0.46%1.5M | 600.51%33.04M | --0 |
| Net other investing changes | -94.00%3K | -86.56%185K | 838.89%507K | 51.77%1.5M | -64.29%20K | 51.52%50K | --1.38M | -94.00%54K | 353.67%989K | --56K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 6.72%-22.86M | -23.21%-21.69M | -17.64%-17.86M | 95.39%-87.95M | -27.72%-30.65M | -95.63%-24.51M | -239.10%-17.61M | 99.19%-15.18M | -2,005.56%-1.91B | 27.15%-24M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -62.29%-10.38M | -76.09%-10.38M | -69.51%-26.85M | -102.20%-35.98M | 24.42%-7.85M | -352.81%-6.4M | -46.33%-5.9M | -100.96%-15.84M | 9,803.81%1.64B | 32.03%-10.39M |
| Net issuance payments of debt | -35.47%-10.41M | -103.80%-15.62M | -71.37%-13M | -101.87%-30.65M | 27.15%-7.72M | -236.78%-7.68M | -225.80%-7.67M | -100.46%-7.58M | 270,496.54%1.64B | -6,564.78%-10.6M |
| Proceeds from stock option exercised by employees | 57.02%2.81M | 41.80%2.92M | -12.28%150K | -54.22%4.02M | --0 | -63.59%1.79M | 11,355.56%2.06M | -94.25%171K | -6.26%8.79M | -63.47%879K |
| Net other financing activities | -453.08%-2.78M | 890.10%2.32M | -66.17%-14M | 28.41%-9.35M | 80.66%-129K | -388.35%-503K | 82.71%-293K | 20.48%-8.43M | 49.05%-13.06M | 96.19%-667K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -62.29%-10.38M | -76.09%-10.38M | -69.51%-26.85M | -102.20%-35.98M | 24.42%-7.85M | -352.81%-6.4M | -46.33%-5.9M | -100.96%-15.84M | 9,803.81%1.64B | 32.03%-10.39M |
| Net cash flow | ||||||||||
| Beginning cash position | 54.50%302.65M | 13.79%251.42M | 21.76%254.22M | -62.23%208.78M | -19.14%197.19M | -23.39%195.89M | -32.93%220.95M | -62.23%208.78M | 39.57%552.83M | -53.05%243.88M |
| Current changes in cash | -32.89%2.86M | 299.69%49.88M | -89.40%1.08M | 112.64%42.28M | 246.20%52.77M | 155.36%4.26M | 64.63%-24.98M | 104.64%10.23M | -309.13%-334.57M | -204.92%-36.09M |
| Effect of exchange rate changes | 337.36%7.01M | 1,724.10%1.35M | -300.36%-3.88M | 133.37%3.16M | 326.43%4.26M | 28.52%-2.95M | 97.34%-83K | 160.11%1.94M | -191.54%-9.48M | 194.33%999K |
| End cash Position | 58.48%312.51M | 54.50%302.65M | 13.79%251.42M | 21.76%254.22M | 21.76%254.22M | -19.14%197.19M | -23.39%195.89M | -32.93%220.95M | -62.23%208.78M | -62.23%208.78M |
| Free cash flow | 24.81%13.23M | 374.61%60.08M | 9.85%26.92M | 144.92%72.53M | 330.15%59.3M | 151.75%10.6M | 75.10%-21.88M | 189.66%24.51M | -186.63%-161.46M | -144.32%-25.77M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data